Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2009
12/01/2009US7626040 Substituted imidazole compounds as KSP inhibitors
12/01/2009US7626033 Compounds for the modulation of PPARγ activity
12/01/2009US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
12/01/2009US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7626029 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents
12/01/2009US7626020 Coupling [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid with N-(Isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl) Pyridine-3-sulphonamide, producing N-(isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide
12/01/2009US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625930 Chromophoric moiety comprises trialkoxyphenylpyridyl groups; biochemical conjugation; for solid phase synthesis of oligonucleotides and oligopeptides; magnetic resonance imaging; positron emission tomography
12/01/2009US7625926 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
12/01/2009US7625921 Bridged ring compounds based on nitrogen-containing rings such as 5,10-dihydro-5,10-ethanobenzo(g)quinoline; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009US7625904 Methods for the treatment of sleep disorders
12/01/2009US7625902 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625896 Pyridylsulfonamide derivatives
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009CA2461100C 4-imidazolin-2-one compounds
12/01/2009CA2432912C Dimeric azo pyridone colorants
12/01/2009CA2374317C Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143507A2 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009WO2009143404A1 Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
11/26/2009WO2009143211A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009143058A1 Bicyclic compounds having activity at the cxcr4 receptor
11/26/2009WO2009143049A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009WO2009143039A2 Heterocyclic compounds as factor ixa inhibitors
11/26/2009WO2009143033A1 Process for the preparation of an orexin receptor antagonist
11/26/2009WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009WO2009142870A1 Compound comprising phenyl pyridine units
11/26/2009WO2009142867A1 Compound comprising phenyl pyridine units
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009141782A1 Tetrahydroisoquinolines as antimalarial agents
11/26/2009WO2009141533A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009WO2009141532A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009WO2009141274A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
11/26/2009WO2009140769A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/26/2009WO2009123948A3 Compounds and compositions as itpkb inhibitors
11/26/2009WO2009115562A3 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
11/26/2009WO2009115557A3 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009WO2009115547A8 Trisubstituted 1, 2, 4 -triazoles as nicotinic acetylcholine receptor modulators
11/26/2009WO2008122858A8 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
11/26/2009WO2007084221A9 Methods and apparatus for identifying subject matter in view data
11/26/2009US20090292123 Ligand, metal complex compound containing the same, and method for producing the same, and method for producing molecular device
11/26/2009US20090292121 Cyanopyridine derivative and use thereof as medicine
11/26/2009US20090291984 Substituted pyrazoles, compositions containing these, method of production and use
11/26/2009US20090291983 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents
11/26/2009US20090291982 New Substituted Oxindole Derivative 352
11/26/2009US20090291981 5-Lipoxygenase-Activating Protein Inhibitor
11/26/2009US20090291967 Small molecule modulators of cell adhesion
11/26/2009US20090291965 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291962 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor
11/26/2009US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
11/26/2009US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009US20090291949 Substitute isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
11/26/2009US20090291940 Aminopyrrolidine compound
11/26/2009US20090289547 Compound comprising phenyl pyridine units
11/26/2009US20090289224 Compound comprising phenyl pyridine units
11/26/2009US20090288707 Novel compounds for electronic material and organic electronic device using the same
11/26/2009CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009CA2725066A1 Bicyclic compounds having activity at the cxcr4 receptor
11/26/2009CA2725045A1 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009CA2724756A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/26/2009CA2724742A1 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
11/26/2009CA2724648A1 Process for the preparation of an orexin receptor antagonist
11/26/2009CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009CA2724430A1 Heterocyclic compounds as factor ixa inhibitors
11/26/2009CA2724426A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009CA2723612A1 Tetrahydroisoquinolines as antimalarial agents
11/25/2009EP2123647A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases
11/25/2009EP2121681A1 Compounds and method for treatment of cancer
11/25/2009EP2121659A1 Modulators of cb1 receptors
11/25/2009EP2121657A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
11/25/2009EP2121655A1 Novel 2-heteroaryl substituted indoles 695
11/25/2009EP2121652A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
11/25/2009EP2121634A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
11/25/2009EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009EP2121627A1 Benzimidazole derivatives
11/25/2009EP2121619A2 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
11/25/2009EP2121617A1 Cb1 receptor modulators
11/25/2009EP2121608A1 Dihydropyridine derivatives useful as protein kinase inhibitors
11/25/2009EP2121600A2 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP2120578A1 Kinase inhibitor compounds
11/25/2009EP2120573A1 Piperidine derivatives
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1828172B1 Pyrrole derivatives having crth2 receptor antagonist activity
11/25/2009EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101589035A Novel imatinib camsylate and method for preparing thereof
1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 1080